ResearchMoz

Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-12-03
No. Of Pages » 82
 This report studies the market for intravenous (IV) access devices utilized by physicians to deliver medication to the patients’ bloodstream through the intravenous route and also to withdraw blood for testing purpose. The global intravenous access devices market is segmented into four categories in this report, namely, IV needles, IV catheters and IV infusion pumps. These product segments have been further classified based on the type of products. The intravenous catheters segment includes midline peripheral catheters and central catheters. Central catheters are further classified as peripherally inserted central catheters (PICC) and centrally inserted catheters. The intravenous infusion pumps segment includes insulin infusion pumps, parenteral feeding infusion pumps, patient...
Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Rise in incidences of target diseases such as cancer and viral infections
3.2.2 Aging of the global population
3.2.2.1 Global Rate of Aging Population
3.2.3 Increase in the development of vaccines
3.2.3.1 Pipeline Vaccines and Research Phase
3.2.4 Technological advancements in product design
3.2.5 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Lack of regulatory approval for intravenous insulin infusion pumps in key markets such as the U.S.
3.3.2 Risk associated with use of needles
3.3.3 Impact Analysis of Market Restraints
3.4 Market Opportunities
3.4.1 Large target patient pool and rise in disposable income in emerging economies
3.5 Porters Five Force Analysis for the Global Intravenous Access Devices Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis
3.6.1 Market Attractiveness Analysis: Global Intravenous Access Devices Market, by Geography 

Chapter 4 Global Intravenous Access Devices Market, by Product Type
4.1 Overview
4.1.1 Global Intravenous Access Devices Market Revenue, by Product Type, 2011-2019 (USD Billion)
4.1.2 Comparative Analysis: Global Intravenous Access Devices Market, by Product Type, 2012 & 2019 (Value %)
4.2 Intravenous Needles
4.2.1 Global Intravenous Needles Market Revenue, 2011 - 2019 (USD Billion)
4.3 Intravenous Catheters
4.3.1 Global Intravenous CatheterMarket Revenue, by Type, 2011 - 2019 (USD Billion)
4.3.2 Midline Peripheral Catheters
4.3.2.1 Global Midline Peripheral Catheter Market Revenue, 2011 - 2019 (USD Billion)
4.3.3 Central Catheters
4.3.3.1 Global Central CathetersMarket Revenue, by Type, 2011 - 2019 (USD Billion)
4.3.3.2 Peripherally Inserted Central Catheters (PICC)
4.3.3.2.1 Global Peripherally Inserted Central Catheter Market Revenue, 2011 - 2019 (USD Billion)
4.3.3.3 Centrally Inserted Central Catheters
4.3.3.3.1 Global Centrally Inserted Central Catheter Market Revenue, 2011 - 2019 (USD Billion)
4.4 Intravenous Infusion Pumps
4.4.1 Global Intravenous Infusion PumpsMarket Revenue, by Type, 2011 - 2019 (USD Billion)
4.4.2 Insulin infusion Pumps
4.4.2.1 Global Intravenous Insulin infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
4.4.3 Parenteral Feeding Infusion Pumps
4.4.3.1 Global Parenteral Feeding Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
4.4.4 Patient Controlled Analgesia (PCA) Infusion Pumps
4.4.4.1 Global Patient Controlled Analgesia (PCA) Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)
4.4.5 Syringe Infusion Pumps
4.4.5.1 Global Syringe Infusion Pumps Market Revenue, 2011 - 2019 (USD Billion)

Chapter 5 Global Intravenous Access Devices Market, by Geography
5.1 Overview
5.1.1 Global Intravenous Access Devices Market Revenue, by Geography, 2011 - 2019 (USD Billion)
5.1.2 Comparative Analysis: Global Intravenous Access Devices Market, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Geriatric Population Statistics (Million), 1991 - 2011
5.3.2 Europe Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Intravenous Access Devices Market Revenue, 2011 - 2019 (USD Billion)

Chapter 6 Competitive Landscape
6.1 Market Share by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Market Strategies for Success
7.1.1 Entrance into long term contract with medical services providers
7.1.2 Product innovations
7.1.3 Broadening of distribution network
7.1.4 Mergers and acquisitions
7.1.5 Investing in emerging markets

Chapter 8 Company Profiles
8.1 Baxter International
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.3 Becton, Dickinson & Company
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 CareFusion Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Covidien Plc
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Strategic overview
8.5.5 Recent developments
8.6 Fresenius Medical Care AG & Co. KGaA
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Strategic Overview
8.6.5 Recent Developments
8.7 Hospira, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.8 Medtronic, Inc.
8.8.1 Company overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Smiths Medical
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Teleflex Incorporated
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Strategies
8.10.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Intravenous Access Devices Market
TABLE 2 Impact Analysis of Market Drivers
TABLE 3 Impact Analysis of Market Restraints
TABLE 4 Global Intravenous Access Devices Market Revenue, by Product Type, 2011 – 2019 (USD Billion)
TABLE 5 Global Intravenous CatheterMarket Revenue, by Type, 2011 – 2019 (USD Billion)
TABLE 6 Global Central CatheterMarket Revenue, by Type, 2011 – 2019 (USD Billion)
TABLE 7 Global Intravenous Infusion PumpsMarket Revenue, by Type, 2011 – 2019 (USD Billion)
TABLE 8 Global Intravenous Access Devices Market Revenue, by Geography, 2011 – 2019 (USD Billion)
TABLE 9 Europe Geriatric Population Statistics (Million), 1991-2011

List of Figures


FIG. 1 Intravenous Access Devices Market Segmentation
FIG. 2 Global Intravenous Access Devices Market, by Product Type, 2012 (USD Billion)
FIG. 3 Global Rate of Aging Population
FIG. 4 Porter’s Five Force Analysis: Global Intravenous Access Devices Market
FIG. 5 Market Attractiveness Analysis: Global Intravenous Access Devices Market, by Geography (2012)
FIG. 6 Comparative Analysis: Global Intravenous Access Devices Market, By Product Type, 2012 & 2019 (Value %)
FIG. 7 Global Intravenous Needles Market Revenue, 2011 – 2019 (USD Billion)
FIG. 8 Global Midline Peripheral Catheter Market Revenue, 2011 – 2019 (USD Billion)
FIG. 9 Global Peripherally Inserted Central Catheter Market Revenue, 2011 – 2019 (USD Billion)
FIG. 10 Global Centrally Inserted Central Catheter Market Revenue, 2011 – 2019 (USD Billion)
FIG. 11 Global Intravenous Insulin infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 12 Global Parenteral Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 13 Global Patient Controlled Analgesia (PCA) Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 14 Global Syringe Infusion Pumps Market Revenue, 2011 – 2019 (USD Billion)
FIG. 15 Comparative Analysis: Global Intravenous Access Devices Market, By Geography, 2012 & 2019 (Value %)
FIG. 16 North America Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 17 Europe Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 18 Asia-Pacific Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 19 Rest of the World (RoW) Intravenous Access Devices Market Revenue, 2011 – 2019 (USD Billion)
FIG. 20 Market Share by Key Players, 2012 (%)
FIG. 21 Baxter International: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 22 B. Braun Melsungen AG: Annual Sales, 2010 – 2012 (USD Million)
FIG. 23 Becton, Dickinson and Company: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 24 CareFusion Corporation: Annual Revenues, 2010 - 2012 (USD Million)
FIG. 25 Covidien Plc: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 26 Fresenius Medical Care AG & Co. KGaA: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 27 Hospira, Inc., Annual Sales: 2010 – 2012 (USD Millions)
FIG. 28 Medtronic, Inc.: Annual Sales, 2010 – 2012 (USD Million)
FIG. 29 Smiths Medical: Annual Sales, 2010 – 2012 (USD Million)
FIG. 30 Teleflex Incorporated: Annual Revenue, 2010 – 2012 (USD Million)

Upcoming Reports:

Biotechnology Reagents Market - Global Industry Size, Share, Trends, Analysis and Forecast, 2011 - 2018
By - Transparency Market Research
Biotechnology reagents are the substances or chemical compound that is added to a system to detect, examine or synthesize other substances. Biotechnology industry mainly combines cellular and molecular biotechnology, human immunology and genetics, focusing mainly upon research and innovations in recombinant DNA technology or genetic engineering. Growth of such industries mainly depends on innovative products. Hence, all this attributes growth opportunities for related markets such as reagents, which depends to a large extent on the market for biotechnology industries. Some of...
Hybrid Cars Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The growing concern over the increasing carbon emissions has forced global automobile industry to develop advance and better vehicles running on alternative fuels. The factors such as Volatile Oil Prices, Shrinking of Fuel Reserves, Government Support and European Emission Standards are some of the factors driving the hybrid cars market. The report anticipates global hybrid automobile industry will witness a CAGR of more than 20 % over the period of 2012-2018. Government support will play a vital role in the growth of this industry.  This research report analyzes...
Obesity Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Obesity can be defined as a medical condition where excess fat deposition leads to adverse health conditions. Obesity increases the chances of diseases related with heart, certain type of cancer, diabetes and osteoarthritis. Obesity has become one of the serious leading healthcare problems across the globe. It is mainly caused by increased fatty intake, reduced physical exercises and sometimes genetic inheritance. Physical exercise and diet management are the main components for the treatment of obesity whereas anti-obesity drugs are also available for fat reduction. However, sometimes...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Fresh Lawsuits Hit General Motors
Jul 30, 2014  
This Tuesday, a lawsuit has hit General Motors on behalf of nearly 650 people regarding the faulty ignition switches in a number of cars, the reason why these cars were recalled from customers, which led to accidents that injured and even killed people.  The lawsuit was filed in the federal court of Manhattan, where dozens of cases against the company over the issue of faulty ignition...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...